The funding will support regulatory and clinical programs leading to the commercialization of the MIRA, as well as for research and development efforts.
MIRA surgical robot from Virtual Incision gets FDA Investigational Device Exemption
Virtual Incision said it has received an investigational device exemption for it Miniaturized In Vivo Robotic Assistant, or MIRA, platform for minimally invasive colon resection surgery.
Virtual Incision raises $20M for MIRA mini surgical robots
Virtual Incision raised $20 million in a Series B financing round for its MIRA (miniaturized in vivo robotic assistant) surgical robotic platform. This brings the total financing for the Lincoln, Neb.-based company, which was founded in 2006, to $51 million. The company also filed for an FDA investigational device exemption for the MIRA platform so…
Virtual Incision raises $10M for miniaturized surgical robot
Virtual Incision has raised $10 million as it continues developing its miniaturized surgical robot.